Journal of Viral Hepatitis

Cover image for Vol. 11 Issue 2

March 2004

Volume 11, Issue 2

Pages 97–190

  1. Review

    1. Top of page
    2. Review
    3. Commentary
    4. Original Articles
    5. Case Report
    6. Letters to the Editor
  2. Commentary

    1. Top of page
    2. Review
    3. Commentary
    4. Original Articles
    5. Case Report
    6. Letters to the Editor
    1. Do Taq-generated RT-PCR products from RNA viruses accurately reflect viral genetic heterogeneity? (pages 108–114)

      B. Mullan, P. Sheehy, F. Shanahan and L Fanning

      Version of Record online: 20 FEB 2004 | DOI: 10.1046/j.1365-2893.2003.00455.x

  3. Original Articles

    1. Top of page
    2. Review
    3. Commentary
    4. Original Articles
    5. Case Report
    6. Letters to the Editor
    1. Dynamic analysis of hepatitis B virus DNA and its antigens in 2.2.15 cells (pages 124–129)

      M.-C. Liu, M. Yu, N.-L. Zhang, W.-B. Gong, Y. Wang, W.-H. Piao, Q.-H. Wang and G.-Q. Wang

      Version of Record online: 20 FEB 2004 | DOI: 10.1046/j.1365-2893.2003.00485.x

      • image
      • image
      • image
    2. Expression of FasL and perforin/granzyme B mRNA in chronic hepatitis B virus infection (pages 130–135)

      J. Y. Lee, D. W. Chae, S. M. Kim, E. S. Nam, M. K. Jang, J. H. Lee, H. Y. Kim and J. Y. Yoo

      Version of Record online: 20 FEB 2004 | DOI: 10.1046/j.1365-2893.2003.00486.x

      • image
      • image
      • image
      • image
    3. Type I interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study (pages 136–140)

      D. Fujiwara, K. Hino, Y. Yamaguchi, Y. Kubo, S. Yamashita, K. Uchida, T. Konishi, H. Nakamura, M. Korenaga, M. Okuda and K. Okita

      Version of Record online: 20 FEB 2004 | DOI: 10.1046/j.1365-2893.2003.00477.x

      • image
    4. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies (pages 141–147)

      R. Idilman, M. Arat, E. Soydan, M. Törüner, İ. Soykan, H. Akbulut, Ö. Arslan, M. Özcan, A. R. Türkyilmaz, M. Bozdayı, S. Karayalçın, D. H. Van Thiel, A. Özden, M. Beksaç and H. Akan

      Version of Record online: 20 FEB 2004 | DOI: 10.1046/j.1365-2893.2003.00479.x

    5. Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death (pages 148–156)

      A. Kasahara, H. Tanaka, T. Okanoue, Y. Imai, H. Tsubouchi, K. Yoshioka, S. Kawata, E. Tanaka, K. Hino, K. Hayashi, S. Tamura, Y. Itoh, K. Kiyosawa, S. Kakumu, K. Okita and N. Hayashi

      Version of Record online: 20 FEB 2004 | DOI: 10.1046/j.1365-2893.2003.00481.x

      • image
    6. Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C (pages 175–182)

      P. Lebray, H. Zylberberg, S. Hue, B. Poulet, F. Carnot, S. Martin, Y. Chretien, S. Pol, S. Caillat-Zuckman, C. Bréchot and B. Nalpas

      Version of Record online: 20 FEB 2004 | DOI: 10.1046/j.1365-2893.2003.00488.x

  4. Case Report

    1. Top of page
    2. Review
    3. Commentary
    4. Original Articles
    5. Case Report
    6. Letters to the Editor
    1. Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C (pages 183–186)

      P. E. Golstein, M. L. Delforge, J. Deviere and P. Marcellin

      Version of Record online: 20 FEB 2004 | DOI: 10.1046/j.1365-2893.2003.00478.x

      • image
  5. Letters to the Editor

    1. Top of page
    2. Review
    3. Commentary
    4. Original Articles
    5. Case Report
    6. Letters to the Editor
    1. Response to Article by Formann et al. (2003) (page 187)

      I. M. Jacobson and J. McHutchison

      Version of Record online: 20 FEB 2004 | DOI: 10.1046/j.1365-2893.2003.00494.x

SEARCH

SEARCH BY CITATION